Cannabis-Wissenschaft

MDMB-4en-PINACA is a fully synthetic cannabinoid, in the Indazole carboxamide group. A widely detected recent-generation synthetic agonist.

5F-MDMB-PINACA (5F-ADB) is a fully synthetic cannabinoid, in the Indazole carboxamide group. A recent-generation synthetic linked to deaths and severe toxicity.

AM-2201 is a fully synthetic cannabinoid, in the Naphthoylindole group. A second-generation Spice agonist with high harm risk.

HU-210 is a fully synthetic cannabinoid, in the Classical cannabinoid group. An extremely potent synthetic, roughly 100-800x THC, used strictly in research.

WIN-55,212-2 is a fully synthetic cannabinoid, in the Aminoalkylindole group. A widely used laboratory cannabinoid agonist.

CP-55,940 is a fully synthetic cannabinoid, in the Cyclohexylphenol group. A Pfizer reference agonist used as a potency benchmark in labs.

JWH-073 is a fully synthetic cannabinoid, in the Naphthoylindole group. An early-generation Spice agonist.

Dexanabinol (HU-211) is a pharmaceutical cannabinoid, in the Synthetic (NMDA antagonist) group. A non-psychotropic synthetic that acts as an NMDA antagonist rather…

Rimonabant is a pharmaceutical cannabinoid, in the CB1 inverse agonist group. An anti-obesity CB1 blocker withdrawn for psychiatric side effects.

Nabiximols is a pharmaceutical cannabinoid, in the THC:CBD botanical extract group. A 1:1 THC:CBD oromucosal spray (Sativex) approved for MS spasticity.